Point-of-Care Lactate Testing Predicts Mortality of Severe Sepsis in a Predominantly HIV Type 1-Infected Patient Population in UgandaMOORE, Christopher C; JACOB, Shevin T; PINKERTON, Relana et al.Clinical infectious diseases. 2008, Vol 46, Num 2, pp 215-222, issn 1058-4838, 8 p.Article

Resurrecting the Triple Threat: Academic Social Responsibility in the Context of Global Health ResearchMANABE, Yukari C; JACOB, Shevin T; THOMAS, David et al.Clinical infectious diseases. 2009, Vol 48, Num 10, pp 1420-1422, issn 1058-4838, 3 p.Article

Activation of P-TEFb at Sites of Dual HIV/TB Infection, and Inhibition of MTB-Induced HIV Transcriptional Activation by the Inhibitor of CDK9, Indirubin-3'-MonoximeTOOSSI, Zahra; MIANDA WU; HIRSCH, Christina S et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 182-187, issn 0889-2229, 6 p.Article

Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosisCOLLINS, Kalonji R; MAYANJA-KIZZA, Harriet; SULLIVAN, Barbara A et al.Journal of acquired immune deficiency syndromes (1999). 2000, Vol 24, Num 5, pp 408-417, issn 1525-4135Article

Dynamic variation in the cellular origin of HIV type 1 during treatment of tuberculosis in dually infected subjectsTOOSSI, Zahra; MAYANJA-KIZZA, Harriet; LAWN, Stephen D et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 93-100, issn 0889-2229, 8 p.Article

Autopsy acceptance rate and reasons for decline in Mulago Hospital, Kampala, UgandaCOX, Janneke A; LUKANDE, Robert L; KATEREGGA, Alice et al.TM & IH. Tropical medicine & international health. 2011, Vol 16, Num 8, pp 1015-1018, issn 1360-2276, 4 p.Article

Induction of HIV Type 1 Expression Correlates with T Cell Responsiveness to Mycobacteria in Patients Coinfected with HIV Type 1 and Mycobacterium tuberculosisCANADAY, David H; MIANDA WU; SHIGOU LU et al.AIDS research and human retroviruses. 2009, Vol 25, Num 2, pp 213-216, issn 0889-2229, 4 p.Article

Therapeutic Evaluation of Polyamine Analogue Drug Candidates against Enterocytozoon bieneusi in a SCID Mouse ModelXIAOCHUAN FENG; REDDY, Venudhar K; MAYANJA-KIZZA, Harriet et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2417-2423, issn 0066-4804, 7 p.Article

Systemic Immune Activation and Microbial Translocation in Dual HIV/Tuberculosis-Infected SubjectsTOOSSI, Zahra; FUNDERBURG, Nicholas T; SIRDESHMUK, Sohani et al.The Journal of infectious diseases. 2013, Vol 207, Num 12, pp 1841-1849, issn 0022-1899, 9 p.Article

Hypoglycemia at admission is associated with inhospital mortality in Ugandan patients with severe sepsisSSEKITOLEKO, Richard; JACOB, Shevin T; SCHELD, W. Michael et al.Critical care medicine. 2011, Vol 39, Num 10, pp 2271-2276, issn 0090-3493, 6 p.Article

Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral TherapyWORODRIA, William; MASSINGA-LOEMBE, Marguerite; COLEBUNDERS, Robert et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 1, pp 32-37, issn 1525-4135, 6 p.Article

Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adultsBYAKIKA-KIBWIKA, Pauline; LAMORDE, Mohammed; BOFFITO, Marta et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, Num 5, pp 1113-1117, issn 0305-7453, 5 p.Article

Early virological response of zidovudine/ lamivudine/abacavir for patients co-infected with HIV and tuberculosis in UgandaSRIKANTIAH, Padmini; WALUSIMBI, Maria N; KAYANJA, H. Kose et al.AIDS (London). 2007, Vol 21, Num 14, pp 1972-1974, issn 0269-9370, 3 p.Article

The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomesTRACHTENBERG, Joel D; KAMBUGU, Andrew D; MCKELLAR, Mehri et al.International journal of infectious diseases. 2007, Vol 11, Num 6, pp 524-530, issn 1201-9712, 7 p.Article

Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral TherapyKAMBUGU, Andrew; MEYA, David B; BOULWARE, David R et al.Clinical infectious diseases. 2008, Vol 46, Num 11, pp 1694-1701, issn 1058-4838, 8 p.Article

A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countriesCOLEBUNDERS, Robert; MOSES, Kamya R; QUINN, Thomas C et al.Lancet. Infectious diseases (print). 2006, Vol 6, Num 1, pp 53-59, issn 1473-3099, 7 p.Article

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosisWALLIS, Robert S; KYAMBADDE, Peter; OKWERA, Alphonse et al.AIDS (London). 2004, Vol 18, Num 2, pp 257-264, issn 0269-9370, 8 p.Article

Macrophage-activating cytokines in human immununodeficiency virus type 1-infected and -uninfected patients with pulmonary tuberculosisMAYANJA-KIZZA, Harriet; JOHNSON, John L; AUNG, Htin et al.The Journal of infectious diseases. 2001, Vol 183, Num 12, pp 1805-1809, issn 0022-1899Article

Effects of Antiretroviral Therapy on Immune Function of HIV-infected Adults with Pulmonary Tuberculosis and CD4⁺ >350 Cells/mm³LANCIONI, Christina L; MAHAN, C. Scott; BOOM, W. Henry et al.The Journal of infectious diseases. 2011, Vol 203, Num 7, pp 992-1001, issn 0022-1899, 10 p.Article

Urinary Lipoarabinomannan as Predictor for the Tuberculosis Immune Reconstitution Inflammatory SyndromeCONESA-BOTELLA, Anali; MASSINGA LOEMBE, Marguerite; KESTENS, Luc et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 5, pp 463-468, issn 1525-4135, 6 p.Article

Activation of β-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosisMAYANJA-KIZZA, Harriet; WAJJA, Anne; ELLNER, Jerrold et al.The Journal of infectious diseases. 2001, Vol 183, Num 12, pp 1801-1804, issn 0022-1899Article

Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfectionWORODRIA, William; MENTEN, Joris; COLEBUNDERS, Robert et al.Antiviral therapy (London). 2012, Vol 17, Num 5, pp 841-848, issn 1359-6535, 8 p.Article

Evaluation of Dynabeads and Cytospheres Compared With Flow Cytometry to Enumerate CD4+ T Cells in HIV-Infected Ugandans on Antiretroviral TherapyLUTWAMA, Fred; SERWADDA, Ronnie; SPACEK, Lisa A et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 48, Num 3, pp 297-303, issn 1525-4135, 7 p.Article

Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis : A phase 2 clinical trial in ugandaMAYANJA-KIZZA, Harriet; JONES-LOPEZ, Edward; OKWERA, Alphonse et al.The Journal of infectious diseases. 2005, Vol 191, Num 6, pp 856-865, issn 0022-1899, 10 p.Article

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapyKAMYA, Moses R; MAYANJA-KIZZA, Harriet; KATABIRA, Elly et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 187-193, issn 1525-4135, 7 p.Conference Paper